CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 75 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $11 | -100.0% | 102,700 | -87.0% | 0.00% | – |
| Q3 2022 | $130,000 | -68.3% | 790,531 | -51.4% | 0.00% | – |
| Q2 2022 | $410,000 | -33.3% | 1,626,860 | +40.6% | 0.00% | -100.0% |
| Q1 2022 | $615,000 | +307.3% | 1,157,191 | +371.0% | 0.00% | – |
| Q4 2021 | $151,000 | -87.4% | 245,700 | -74.5% | 0.00% | -100.0% |
| Q4 2020 | $1,203,000 | -28.7% | 962,100 | +2.7% | 0.00% | -50.0% |
| Q3 2020 | $1,687,000 | +4.9% | 937,136 | +389.1% | 0.00% | +100.0% |
| Q2 2020 | $1,608,000 | +91.0% | 191,600 | +14.9% | 0.00% | – |
| Q2 2018 | $842,000 | -34.5% | 166,822 | -11.8% | 0.00% | -100.0% |
| Q3 2016 | $1,285,000 | +192.7% | 189,200 | +28.8% | 0.00% | +100.0% |
| Q2 2016 | $439,000 | +330.4% | 146,900 | +159.5% | 0.00% | – |
| Q1 2016 | $102,000 | +161.5% | 56,600 | +137.8% | 0.00% | – |
| Q4 2015 | $39,000 | – | 23,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $1,273,000 | 0.73% |
| ETF MANAGERS GROUP, LLC | 7,062,485 | $1,787,000 | 0.05% |
| Ikarian Capital, LLC | 862,527 | $217,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 457,209 | $115,000 | 0.02% |
| Platform Technology Partners | 33,750 | $9,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 910,006 | $230,000 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $7,683 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,029,171 | $1,016,000 | 0.00% |
| Vident Investment Advisory, LLC | 267,612 | $67,000 | 0.00% |
| Aries Wealth Management | 15,400 | $4,000 | 0.00% |